Ayalon Insurance (TASE:AYAL) has drawn investor attention after reporting its Q2 and first half 2026 results, with updated net income and earnings per share figures, alongside a declared cash dividend linked to an upcoming ex dividend date.
The earnings release and dividend announcement come after a strong run in Ayalon Insurance’s share price, with a 1 month share price return of 15.9% and a 7 day share price return of 6.77%. The 3 month share price return has slipped 4.56% after a very large 3 year total shareholder return and a 149.52% 1 year total shareholder return, suggesting long term momentum with some recent cooling.
Compare Ayalon Insurance's momentum and dividend news with a curated group of resilient balance sheet opportunities by reviewing the list of solid balance sheet and fundamentals (426 results).
Ayalon Insurance is up sharply over the past year with fresh earnings and a new dividend now in play. After this run, does the current price still offer an attractive balance between risk and potential reward?
Ayalon Insurance currently trades on a P/E of 10.2x, which is higher than the peer average of 8.9x, while the SWS DCF model places fair value at ₪171.23 compared with the last close of ₪165.5.
The P/E ratio compares what investors are paying for each unit of current earnings. For an insurer like Ayalon Insurance, it gives a quick sense of how the market is pricing its profitability in relation to other insurers and the wider local peer group.
At 10.2x earnings, the stock is priced above its peer average of 8.9x, which suggests investors are willing to pay a premium multiple compared to similar companies. That sits alongside the SWS DCF estimate that values the shares around 3.3% above the current price at ₪171.23. This points to a market view that recognises the company’s earnings profile while still keeping the valuation close to the modelled cash flow value rather than at a steep premium or discount.
Compared with the broader Asian Insurance industry average P/E of 11.3x, Ayalon Insurance trades on a lower multiple, which puts it between cheaper local peers and the wider regional group. The stock appears more expensive than its immediate peer set but cheaper than the regional industry average, which suggests the current P/E multiple is roughly in line with how the market is weighing its earnings strength against sector benchmarks.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price-to-earnings of 10.2x (ABOUT RIGHT)
However, investors in Ayalon Insurance still face risks from potential pressure on insurance margins or capital buffers, which could challenge the recent share price momentum.
Find out about the key risks to this Ayalon Insurance narrative.
The SWS DCF model values Ayalon Insurance shares at ₪171.23, compared with the current price of ₪165.5, which implies the stock trades about 3.3% below that estimate. That is only a small gap. Could that limited margin of safety be enough for your approach?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Ayalon Insurance for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 267 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
If this mix of strong share price history, fair value signals and fresh earnings leaves you on the fence, move quickly and weigh the trade off yourself. To understand the balance between the potential upside and the issues investors worry about, review the 2 key rewards and 1 important warning sign.
If Ayalon Insurance has caught your eye, do not stop there. Use the tools available to widen your watchlist and pressure test your next move.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com